Edition:
United Kingdom

Agile Therapeutics Inc (AGRX.OQ)

AGRX.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
18 Apr 2019
Change (% chg)

$-0.03 (-2.13%)
Prev Close
$1.41
Open
$1.40
Day's High
$1.41
Day's Low
$1.34
Volume
26,308
Avg. Vol
81,516
52-wk High
$2.98
52-wk Low
$0.23

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.111
Sep '18 0.00 -0.110
Jun '18 0.00 -0.156
Mar '18 0.00 -0.200
FY 2017 Dec '17 0.00 -0.182
Sep '17 0.00 -0.222
Jun '17 0.00 -0.259
Mar '17 0.00 -0.261
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 4 0.00 0.00 0.00 --
Quarter Ending Sep-19 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 16.86
Year Ending Dec-20 5 20.53 35.41 5.03 94.72
Earnings (per share)
Quarter Ending Jun-19 4 -0.09 -0.09 -0.10 --
Quarter Ending Sep-19 4 -0.09 -0.08 -0.11 --
Year Ending Dec-19 4 -0.36 -0.32 -0.39 -0.81
Year Ending Dec-20 6 -0.41 0.11 -0.76 0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.10
P/E Low - Last 5 Yrs. -- 47.94 23.42
Beta 2.07 1.08 0.87
Price to Sales (TTM) -- 49.51 8.39
Price to Book (MRQ) 5.23 10.13 5.27
Price to Tangible Book (MRQ) 6.20 13.74 6.74
Price to Cash Flow (TTM) -- 56.17 24.13
% Owned Institutions 78.05 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.02 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.06 13.46
Sales (TTM) vs TTM 1 Yr. Ago -- 49.01 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago 11.73 75.31 47.73
EPS (TTM) vs TTM 1 Yr. Ago 16.43 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 3.37 3.57 2.98
LT Debt to Equity (MRQ) 27.06 18.63 11.32
Total Debt to Equity (MRQ) 47.59 31.30 16.01
Interest Coverage (TTM) -15.94 -43.11 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 52.41
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.67 12.41
Operating Margin (TTM) -- -184.95 5.77
Operating Margin - 5 Yr. Avg. -- -127.15 8.01
Pre-Tax Margin (TTM) -- -175.66 4.79
Pre-Tax Margin - 5 Yr. Avg. -- -132.95 8.29
Net Profit Margin (TTM) -- -182.38 1.52
Net Profit Margin - 5 Yr. Avg. -- -137.34 4.70
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,653,551 820,412,980
Net Income/Employee (TTM) -1,471,947 513,615 92,866,230
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -46.27 6.38 10.60
Return on Assets - 5 Yr. Avg. -- 5.47 11.78
Return on Investment (TTM) -55.62 8.91 13.83
Return on Investment - 5 Yr. Avg. -- 6.79 15.32
Return on Equity (TTM) -67.67 10.06 15.25
Return on Equity - 5 Yr. Avg. -- 8.32 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 26.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Agile Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 52.45 47.19 94 99
13 Week 41.82 34.92 85 95
26 Week 79.93 66.25 89 97
52 Week -26.53 -37.73 32 69
YTD -7.19 -18.50 37 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 54.22%
# of Holders: 39
Total Shares Held: 23,430,765
3 Mo. Net Change: 8,233,831
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 3
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.